Evidence map›Paper›PMID 33876162›Full record

ArticleAnalytical methods : advancing methods and applications2021

Inductively coupled plasma optical emission spectroscopy as a tool for evaluating lateral flow assays.

Jenna M DeSousa, Micaella Z Jorge, Hayley B Lindsay, Frederick R Haselton, David W Wright, Thomas F Scherr

Open access · greenAbstract read
In one paragraph

Article in Analytical methods : advancing methods and applications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Characterization and utility of immobilized metal affinity-functionalized cellulose membranes for point-of-care malaria diagnostics.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jenna M DeSousaDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA. thomas.f.scherr@vanderbilt.edu david.w.wright@vanderbilt.edu.ORCID 0000-0003-2628-5844
Micaella Z JorgeDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA. thomas.f.scherr@vanderbilt.edu david.w.wright@vanderbilt.edu.ORCID 0000-0001-6083-7986
Hayley B LindsayDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Frederick R HaseltonDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA. thomas.f.scherr@vanderbilt.edu david.w.wright@vanderbilt.edu and Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0003-4282-5222
David W WrightDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA. thomas.f.scherr@vanderbilt.edu david.w.wright@vanderbilt.edu.ORCID 0000-0002-1415-9931
Thomas F ScherrDepartment of Chemistry, Vanderbilt University, Nashville, TN, USA. thomas.f.scherr@vanderbilt.edu david.w.wright@vanderbilt.edu.ORCID 0000-0002-7077-535X
Vanderbilt University · US

Funding

Vanderbilt-Zambia Network for Innovation in Global Health TechnologiesD43TW009348 · FIC · VANDERBILT UNIVERSITY · PI HASELTON, FREDERICK R, HEIMBURGER, DOUGLAS CORBETT · 2012 to 2016
$1.7M
Mobile Health and Treat (mHAT) for Malaria EliminationR21TW010635 · FIC · VANDERBILT UNIVERSITY · PI WRIGHT, DAVID W · 2017 to 2018
$376k
FIC NIH HHS D43 TW009348FIC NIH HHS R21 TW010635
6 · The paper itself

Abstract

Lateral flow assays (LFAs) are immunochromatographic point-of-care devices that have greatly impacted disease diagnosis through their rapid, inexpensive, and easy-to-use form factor. While LFAs have been successful as field-deployable tools, they have a relatively poor limit of detection when compared to more complex methods. Moreover, most design and manufacturing optimization is achieved through time- and resource-intensive brute-force optimization. Despite increased interests in LFA manufacturing, more quantitative tools are needed to study current manufacturing protocols and therefore, optimize and streamline development of these devices further. In this work, we focus on a critical LFA component, colloidal gold conjugated to a detection antibody, one of the most commonly used reporter elements. This study utilizes inductively coupled plasma optical emission spectroscopy (ICP-OES) in conjunction with a lateral flow reader to quantitatively analyze colloidal gold distributions at the read-out test and control lines, as well as residual gold on the conjugate pad and other flow through regions. Our goals are to develop a more rigorous understanding of current LFA designs as well as a quantitative understanding of shortcomings of operational characteristics for future improvement. To our knowledge, this is the first time that ICP-OES has been used to study the initial distribution of colloidal gold on an unused LFA and its redistribution after a test is performed. Using three different brands of commercially available malaria LFAs, gold content was measured within each section of an LFA at varying parasite test concentrations. As expected, the total mass of gold remained unchanged after LFA use; however, the total mass of initial gold and its redistribution varied among manufacturers. Importantly, there are also some inherent inefficiencies that exist in these commercial LFA designs; for example, only 30% of the total gold deposited onto Brand A LFAs binds to the test and control lines, sections of the test that contain interpretable signal. Using information gathered with this method, future devices could be more purposefully engineered to focus on improved binding efficiency, resulting in reduced costs, improved limit of detection, and diminished test-to-test and manufacturer-to-manufacturer variability.

Indexed as

Gold ColloidPoint-of-Care SystemsBiological AssayImmunoassaySpectrum AnalysisGold Colloid

Identifiers

PMID33876162
PMCPMC11095835
OpenAlexW3152843321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.